Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED95 dose of bupivacaine for ultrasound-guided supraclavicular brachial plexus block
2009-011829-13Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupivacaine in None, sponsored by University of Leeds. Primary endpoint: Sensory block to cold in upper arm nerve distributions by 45 minutes. Started Jul 2010; status: completed.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on 2009-011829-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011829-13.